111 related articles for article (PubMed ID: 12494474)
1. Tissue microarray-based analysis shows phospho-beta-catenin expression in malignant melanoma is associated with poor outcome.
Kielhorn E; Provost E; Olsen D; D'Aquila TG; Smith BL; Camp RL; Rimm DL
Int J Cancer; 2003 Feb; 103(5):652-6. PubMed ID: 12494474
[TBL] [Abstract][Full Text] [Related]
2. Tissue microarray analysis of beta-catenin in colorectal cancer shows nuclear phospho-beta-catenin is associated with a better prognosis.
Chung GG; Provost E; Kielhorn EP; Charette LA; Smith BL; Rimm DL
Clin Cancer Res; 2001 Dec; 7(12):4013-20. PubMed ID: 11751495
[TBL] [Abstract][Full Text] [Related]
3. Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations.
Demunter A; Libbrecht L; Degreef H; De Wolf-Peeters C; van den Oord JJ
Mod Pathol; 2002 Apr; 15(4):454-61. PubMed ID: 11950921
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic and nuclear accumulation of beta-catenin is rarely caused by CTNNB1 exon 3 mutations in cutaneous malignant melanoma.
Omholt K; Platz A; Ringborg U; Hansson J
Int J Cancer; 2001 Jun; 92(6):839-42. PubMed ID: 11351304
[TBL] [Abstract][Full Text] [Related]
5. Reduced beta-catenin expression in the cytoplasm of advanced-stage superficial spreading malignant melanoma.
Maelandsmo GM; Holm R; Nesland JM; Fodstad Ø; Flørenes VA
Clin Cancer Res; 2003 Aug; 9(9):3383-8. PubMed ID: 12960126
[TBL] [Abstract][Full Text] [Related]
6. Constitutive activation of Wnt/beta-catenin signaling pathway in migration-active melanoma cells: role of LEF-1 in melanoma with increased metastatic potential.
Murakami T; Toda S; Fujimoto M; Ohtsuki M; Byers HR; Etoh T; Nakagawa H
Biochem Biophys Res Commun; 2001 Oct; 288(1):8-15. PubMed ID: 11594745
[TBL] [Abstract][Full Text] [Related]
7. Lower levels of nuclear beta-catenin predict for a poorer prognosis in localized prostate cancer.
Horvath LG; Henshall SM; Lee CS; Kench JG; Golovsky D; Brenner PC; O'Neill GF; Kooner R; Stricker PD; Grygiel JJ; Sutherland RL
Int J Cancer; 2005 Jan; 113(3):415-22. PubMed ID: 15455387
[TBL] [Abstract][Full Text] [Related]
8. Loss of beta-catenin expression associated with disease progression in malignant melanoma.
Kageshita T; Hamby CV; Ishihara T; Matsumoto K; Saida T; Ono T
Br J Dermatol; 2001 Aug; 145(2):210-6. PubMed ID: 11531781
[TBL] [Abstract][Full Text] [Related]
9. [Nuclear beta-catenin localization is not sufficient for canonical Wnt signaling activation in human meianoma cell lines].
Kulikova KV; Posviatenko AV; Gnuchev NV; Georgiev GP; Kibardin AV; Larin SS
Mol Biol (Mosk); 2011; 45(5):884-91. PubMed ID: 22393786
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of cytoplasmic p27 expression in human melanoma.
Chen G; Cheng Y; Zhang Z; Martinka M; Li G
Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2212-21. PubMed ID: 21828232
[TBL] [Abstract][Full Text] [Related]
11. A survival-stratification model of human colorectal carcinomas with beta-catenin and p27kip1.
Cheah PY; Choo PH; Yao J; Eu KW; Seow-Choen F
Cancer; 2002 Dec; 95(12):2479-86. PubMed ID: 12467060
[TBL] [Abstract][Full Text] [Related]
12. Beta-catenin in soft tissue sarcomas: expression is related to proliferative activity in high-grade sarcomas.
Kuhnen C; Herter P; Müller O; Muehlberger T; Krause L; Homann H; Steinau HU; Müller KM
Mod Pathol; 2000 Sep; 13(9):1005-13. PubMed ID: 11007041
[TBL] [Abstract][Full Text] [Related]
13. Expression of mutant nuclear beta-catenin correlates with non-invasive hepatocellular carcinoma, absence of portal vein spread, and good prognosis.
Mao TL; Chu JS; Jeng YM; Lai PL; Hsu HC
J Pathol; 2001 Jan; 193(1):95-101. PubMed ID: 11169521
[TBL] [Abstract][Full Text] [Related]
14. Beta-catenin expression in benign and malignant pilomatrix neoplasms.
Hassanein AM; Glanz SM
Br J Dermatol; 2004 Mar; 150(3):511-6. PubMed ID: 15030335
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of beta-catenin nuclear expression in hepatocellular carcinoma.
Fujito T; Sasaki Y; Iwao K; Miyoshi Y; Yamada T; Ohigashi H; Ishikawa O; Imaoka S
Hepatogastroenterology; 2004; 51(58):921-4. PubMed ID: 15239213
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical patterns in rectal cancer: application of tissue microarray with prognostic correlations.
Fernebro E; Bendahl PO; Dictor M; Persson A; Fernö M; Nilbert M
Int J Cancer; 2004 Oct; 111(6):921-8. PubMed ID: 15300804
[TBL] [Abstract][Full Text] [Related]
17. E-cadherin/catenin complex in benign and malignant melanocytic lesions.
Silye R; Karayiannakis AJ; Syrigos KN; Poole S; van Noorden S; Batchelor W; Regele H; Sega W; Boesmueller H; Krausz T; Pignatelli M
J Pathol; 1998 Dec; 186(4):350-5. PubMed ID: 10209482
[TBL] [Abstract][Full Text] [Related]
18. Decreased E-cadherin augments beta-catenin nuclear localization: studies in breast cancer cell lines.
Yang SZ; Kohno N; Yokoyama A; Kondo K; Hamada H; Hiwada K
Int J Oncol; 2001 Mar; 18(3):541-8. PubMed ID: 11179484
[TBL] [Abstract][Full Text] [Related]
19. Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma.
Weeraratna AT; Jiang Y; Hostetter G; Rosenblatt K; Duray P; Bittner M; Trent JM
Cancer Cell; 2002 Apr; 1(3):279-88. PubMed ID: 12086864
[TBL] [Abstract][Full Text] [Related]
20. Aberrant nuclear localization and gene mutation of beta-catenin in low-grade adenocarcinoma of fetal lung type: up-regulation of the Wnt signaling pathway may be a common denominator for the development of tumors that form morules.
Nakatani Y; Masudo K; Miyagi Y; Inayama Y; Kawano N; Tanaka Y; Kato K; Ito T; Kitamura H; Nagashima Y; Yamanaka S; Nakamura N; Sano J; Ogawa N; Ishiwa N; Notohara K; Resl M; Mark EJ
Mod Pathol; 2002 Jun; 15(6):617-24. PubMed ID: 12065775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]